Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...

Atherosclerosis IV: Nursing Management

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Added Sugars Drive Insulin Resistance, Hyperinsulinemia, Hypertension, Type 2 Diabetes and Coronary Heart Disease.

Missouri medicine·2023

Same author

Nutraceutical activation of Sirt1: a review.

Open heart·2022

Same author

Nutraceutical Prevention of Diabetic Complications-Focus on Dicarbonyl and Oxidative Stress.

Current issues in molecular biology·2022

Same author

Monounsaturated Fat vs Saturated Fat: Effects on Cardio-Metabolic Health and Obesity.

Missouri medicine·2022

Same author

Ferulic acid and berberine, via Sirt1 and AMPK, may act as cell cleansing promoters of healthy longevity.

Open heart·2022

Same author

Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity.

Open heart·2022

Search research articles

Related Experiment Videos

CoQ10 and L-carnitine for statin myalgia?

James J DiNicolantonio¹

¹Wegmans Pharmacy, 500 South Meadow Street Ithaca, Ithaca, NY 14850, USA. jjdinicol@gmail.com

Expert Review of Cardiovascular Therapy

|November 30, 2012

Summary

Statins reduce cardiovascular events but may cause muscle pain by lowering coenzyme Q10 (CoQ10). This abstract explores if CoQ10 supplements can alleviate statin-induced myopathy, a common clinical concern.

Area of Science:

Biochemistry
Cardiology
Pharmacology

Background:

Statins are crucial for cardiovascular disease (CVD) prevention, reducing events and mortality.
Statin efficacy stems from inhibiting HMG-CoA reductase, lowering cholesterol and mevalonate.
Mevalonate pathway inhibition reduces coenzyme Q10 (CoQ10) production.

Purpose of the Study:

To investigate the potential role of coenzyme Q10 (CoQ10) in mitigating statin-associated muscle pain (myopathy).
To address the clinical question regarding CoQ10 supplementation for statin-induced myalgia.

Main Methods:

This abstract does not specify methods, but implies a review or clinical consideration of CoQ10's role.
Focuses on the biochemical link between statins, CoQ10, and muscle function.

Related Experiment Videos

Main Results:

Statin use leads to decreased CoQ10 levels.
Reduced CoQ10 is theorized to contribute to statin-associated muscle pain (myalgia).

Conclusions:

Statin-induced myopathy is a significant side effect impacting patient adherence.
The potential therapeutic benefit of CoQ10 for statin myopathy requires further clinical evaluation.